Fu-Dong Shi - Selected Publications#

1. Li J#, Meng X#, Shi FD#, Jing J#, Gu HQ, Jin A, Jiang Y, Li H, Johnston SC, Hankey GJ, Easton DJ, Chang L, Shi P,Wang L, Zhuang X, Li H, Zang Y, Zhang J, Sun Z, Liu D, Li Y, Yang H, Zhao J, Yu W, Wang A, Pan Y, Lin J, Xie X, Jin WN, Li S, Niu S, Wang Y, Zhao X, Li Z, Liu L, Zheng H, Wang Y; CHANCE-3 Investigators. Colchicine in patients with acute ischaemic stroke or transient ischaemic attack (CHANCE-3): multicentre, double blind, randomised, placebo controlled trial. British Medical Journal. 2024 Jun 26:385:e079061. # Co-first author.

2. Zhang C, Shi FD.Targeting B cells in neuromyelitis optica spectrum disorder. Lancet Neurology. 2024,23:549-550.

3.Jiang S, Li X, Li Y, Chang Z, Yuan M, Zhang Y, Zhu H, Xiu Y, Cong H, Yin L, Yu ZW, Fan J, He W, Shi K, Tian DC, Zhang J, Verkhratsky A, Jin WN*, Shi FD. APOE from patient-derived astrocytic extracellular vesicles alleviates neuromyelitis optica spectrum disorder in a mouse model. Science Translational Medicine. 2024;16(736):eadg5116.

4. Li Z, Zhang C, Chang T, Zhang X, Yang H, Gao F, Feng J, Liu H, Chen S, Wang L, Yang C, Li H, Pan Y, Palace J, Shi FD. A multicentre, prospective, double-blind study comparing the accuracy of autoantibody diagnostic assays in myasthenia gravis: the SCREAM study. Lancet Reginal Health West Pacific. 2023, 38:1-9.

5. Shi K, Li H, Chang T, He W, Kong Y, Qi C, Li R, Huang H, Zhu Z, Zheng P, Ruan Z, Zhou J, Shi FD, Liu Q. Bone marrow hematopoiesis drives multiple sclerosis progression. Cell. 2022;185: 1-14.

6. Li Z, Li Y, Han J, Zhu Z, Li M, Liu Q, Wang Y, Shi FD. Formyl peptide receptor 1 signaling potentiates inflammatory brain injury. Science Translational Medicine. 2021;13(605):eabe9890.

7. Zhang C, Zhang M, Qiu W, Zhang X, Ma H, Zhu Z, Yang CS, Jia D, Zhang TX, Yuan M, Feng Y, Yang L, Lu W, Yu C, Bennett J, Shi FD. Tocilizumab versus azathioprine in neuromyelitis optica spectrum disorder (TANGO). Lancet Neurology. 2020;19: 391-401.

8. Liu Q, Jin WN, Liu Y, Shi K, Sun H, Zhang F, Zhang C, Gonzales R, Sheth KN, La Cava A, Shi FD. Brain ischemia suppresses immunity in the periphery and brain via different neurogenic innervations. Immunity. 2017;46:474-487.

9. Fu Y, Liu Q, Anrather J, Shi FD. Immune interventions in stroke. Nature Review Neurology. 2015;11:524-35.

10. Liu Q, Sanai N, Jin WN, La Cava A, Van Kaer L, Shi FD. Neural stem cells sustain natural killer cells that dictate recovery from brain inflammation. Nature Neuroscience. 2016; 19:243-52.

11. Gan Y, Liu Q, Wu W, Yin J, Tang Z, Turner G, Chen J, Wang Y, Lanrent J, Yokayama W, Shi FD. Ischemic neurons recruit NK cells that accelerate brain infarction. Proc Natl Acad Sci USA. 2014;111:2704-9.

12. Shi FD, Ljunggren HG, La Cava A, Van Kaer, L. Organ-specific features of NK cells. Nature Review Immunology. 2011;11;658-671.

13. Shi FD, Wang H, Li H, Hong S, Tanihuchi M, Link H, Van Kaer L, Ljunggren HG. Natural killer cells determine the outcome of B cell-mediated autoimmunity. Nature Immunology. 2000;1:245-251.

Total publications: >250 (can be viewed at: https://pubmed.ncbi.nlm.nih.gov/?term=shi+fd).